Technological development, increasing complexity of both products and services, and the financial crisis, led to the decision by the EU to improve the functioning of the financial markets and to strengthen investor protection through the introduction of MiFID II. MiFID II came into effect on 3 January 2018 and governs both the manner in which firms offer services within the EU as well as determining the rules, systems and controls surrounding the operation of trading venues.
Outlined below is a short overview of Liberum’s current approach to MiFID II as well as the relevant contact details should you have any further enquiries.
In relation to MiFID II’s best execution requirement, Liberum makes the relevant RTS disclosures on its website. RTS disclosures can be found here.
Our Execution Policy can be found here.
For further information regarding our approach to best execution please email email@example.com
Where possible Liberum reports all trading on venue.
Liberum transaction reports at the client order level using the DEAL capacity.
For further information regarding our approach to trade and transaction reporting please email firstname.lastname@example.org
MiFID II’s unbundled research requirement has inspired two primary models across the small and mid-cap broking market: the first being a corporate sponsored research approach and the second being a choice between, or a combination of, payment through an institutional client’s own P&L or by way of a Research Payment Account (RPA). We have taken the view that our research, being highly regarded and valued across our client-base, could potentially be undermined if the corporate sponsored route was implemented. Accordingly, we have chosen to charge our institutional clients for our research. If you would like to receive our research, please contact the MiFID II team at email@example.com for further information regarding our research offering, costs and what new documentation will be required.
Liberum is not an RPA administrator, but will be able to support collection via transactional and accounting methods.
Liberum is not a systematic internaliser.
Legal Entity: Liberum Capital Limited
FCA FRN: 465050
NEW YORK OFFICE
Legal Entity: Liberum Capital Inc
FINRA: CRD# 148135
SEC: SEC# 8-67976